Open an account

Montvale Technologies

IVVI · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed ·
No price history for this range.

About IVVI

Ivivi Technologies, Inc. engages in the design, development, and commercialize of proprietary electrotherapeutic technologies for the non-invasive treatment of acute and chronic disorders of soft tissue. The company is headquartered in Northvale, New Jersey and currently employs 15 full-time employees. The company went IPO on 2006-10-19. The firm has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The firm is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The firm is developing technology for other therapeutic medical markets.

Employees
15
Headquarters
Northvale, New Jersey
Listed
Oct 19, 2006
Sector
Health Care
Industry
Health Care Equipment & Supplies

IVVI key statistics

Market cap
1.12K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
105
Volume
105
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

Montvale Technologies (IVVI) at a glance

As of Aug 3, 2026, Montvale Technologies (IVVI) shares are priced at $0.0001, giving the company a market cap of 1.12K and a price-to-earnings ratio of 0.00.

Volume so far is 105 shares, in line with the average of 105 shares a day.

Over the past year Montvale Technologies has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

Montvale Technologies met or beat analyst EPS estimates in 3 of the last 7 quarters. In Q1 FY09 it reported -$0.21 per share against an estimate of -$0.204.

IVVI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 7 quarters, by 6.7% on average.

  1. Q3 FY07: reported -$0.28 per share against an estimate of -$0.204
  2. Q4 FY07: reported -$0.15 per share against an estimate of -$0.1785
  3. Q1 FY08: reported -$0.15 per share against an estimate of -$0.1173
  4. Q2 FY08: reported -$0.19 per share against an estimate of -$0.1972
  5. Q3 FY08: reported -$0.20 per share against an estimate of -$0.1904
  6. Q4 FY08: reported -$0.21 per share against an estimate of -$0.2108
  7. Q1 FY09: reported -$0.21 per share against an estimate of -$0.204

Similar companies

Companies in the same industry as Montvale Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.